SH3RF1 antibody (Middle Region)
Quick Overview for SH3RF1 antibody (Middle Region) (ABIN631195)
Target
See all SH3RF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- SH3 RF1 antibody was raised against the middle region of SH3 F1
-
Purification
- Affinity purified
-
Immunogen
- SH3 RF1 antibody was raised using the middle region of SH3 F1 corresponding to a region with amino acids LLKLLSGASTKRKPRVSPPASPTLEVELGSAELPLQGAVGPELPPGGGHG
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SH3RF1 Blocking Peptide, (ABIN940541), is also available for use as a blocking control in assays to test for specificity of this SH3RF1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SH0 F1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SH3RF1 (SH3 Domain Containing Ring Finger 1 (SH3RF1))
-
Alternative Name
- SH3RF1
-
Background
- SH3RF1 acts as a scaffold protein, contributes to Rac-induced signal transduction such as JNKs (MAPK8 and MAPK9) activation and induces apoptosis. Within a signaling complex, it probably recruits protein kinases such as MAP3K10 or MAP3K11 which are in turn activated leading to the sequential activation of MAP2K4, MAP2K7 and JNKs (MAPK8 and MAPK9). SH3RF1 may be involved in targeting of HIV-1 GAG and GAG-POL polyproteins to the plasma membrane.
-
Molecular Weight
- 93 kDa (MW of target protein)
Target
-